My Multiple Myeloma has spread to my bones — how is this treated

Bone Involvement in Multiple Myeloma: Treatment Approaches

I understand this is concerning. Bone involvement is actually very common in multiple myeloma—in fact, most people with myeloma experience bone damage. Let me explain what's happening and how it's typically managed.

Why Myeloma Affects Bones

According to the NCCN Guidelines for Patients: Multiple Myeloma, myeloma cells build up in your bone marrow (the spongy center inside bones where blood cells are made). As these cancer cells multiply, they release substances that break down bone tissue, leading to:

• Weakened bones that fracture more easily
• Bone pain (often in the back)
• Lytic lesions (areas where bone looks like it has cracks)
• High calcium levels in the blood (from bone breakdown)

How Bone Involvement is Treated

Treatment for myeloma-related bone disease involves two main strategies:

1. Bone-Building Therapy (Primary Approach)

The NCCN Guidelines recommend medications that strengthen bones and protect them from further damage:

• Bisphosphonates (like Zometa) or Denosumab (Xgeva) — these are the standard treatments
• These drugs help prevent fractures and reduce bone pain
• They work by slowing the breakdown of bone tissue
• Typically given as infusions or injections on a regular schedule

2. Cancer Treatment (Addresses the Root Cause)

Your primary myeloma treatment is equally important because controlling the cancer itself reduces bone damage. According to NCCN Guidelines, your main treatment typically includes:

• Multi-drug combinations (usually 3-4 medications together), which may include:
  • Targeted therapies (proteasome inhibitors like bortezomib/Velcade)
  • Immunomodulators (like lenalidomide/Revlimid)
  • Monoclonal antibodies (like daratumumab/Darzalex)
  • Corticosteroids
• Hematopoietic cell transplant (stem cell transplant) — if you're a candidate
• These treatments reduce myeloma cells, which slows bone damage

3. Supportive Care for Bone Pain

• Radiation therapy to specific painful bone areas
• Pain management medications
• Calcium and vitamin D supplements to support bone health

Important Points About Bone-Targeted Therapy

According to the NCCN Guidelines:

• Bone-building drugs like Xgeva and bisphosphonates prevent fractures and strengthen bones—they're protective, not curative
• These are given alongside your main cancer treatment, not instead of it
• There's a small risk (2-3%) of a rare side effect called osteonecrosis of the jaw, but this is uncommon with proper dental care
• Regular monitoring with imaging (PET/CT, low-dose CT, or MRI scans) helps track how well treatment is working

Questions to Ask Your Oncology Team

Since bone involvement requires coordinated care, consider asking:

1. "What is my current bone damage status? Do I have lytic lesions, and how extensive are they?"
2. "Which bone-building medication do you recommend for me—bisphosphonates or denosumab—and why?"
3. "How often will I receive bone-building therapy, and how long will I stay on it?"
4. "Are there specific areas of bone pain we should address with radiation or other pain management?"
5. "How will we monitor my bones during treatment? What imaging will you use?"
6. "What are the signs I should watch for that might indicate a problem with my bones or treatment?"

The Big Picture

The good news is that bone involvement in myeloma is very treatable. According to NCCN Guidelines, combining effective cancer treatment with bone-protective therapy significantly improves outcomes and quality of life. Many people with myeloma live for years with well-controlled disease and manageable bone symptoms.

Your treatment plan will be personalized based on your specific situation, so these conversations with your care team are essential.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.